ZURA — Zura Bio Limited
$3.36-4.82%
Last close: · regular session
Pre-market $3.35 -0.30% ·
Last 60 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for ZURA in the TickerWise workspace.
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
- Exchange: NASDAQ Capital Market
- Employees: 30
- Website: https://zurabio.com
Latest SEC filings for ZURA
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.